We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$167M |
| 2 |
Apple
AAPL
|
+$66M |
| 3 |
Microsoft
MSFT
|
+$57.3M |
| 4 |
HDFC Bank
HDB
|
+$44M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$81.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$81.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.8M |
| 4 |
Advanced Micro Devices
AMD
|
+$43.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Kyverna Therapeutics
KYTX
$489M
| $5.74K | ﹤0.01% |
+1,439
| New | +$6.89K |
|
|
SCPH
1552
DELISTED
scPharmaceuticals
SCPH
| $5.71K | ﹤0.01% |
+1,668
| New | +$6.39K |
|
1553
Nkarta
NKTX
$171M
| $5.67K | ﹤0.01% |
+2,352
| New | +$7.26K |
|
1554
Solid Biosciences
SLDB
$971M
| $5.64K | ﹤0.01% |
+1,331
| New | +$7.31K |
|
|
MLNK
1555
DELISTED
MeridianLink
MLNK
| $5.47K | ﹤0.01% |
265
-54
| -17% | -$1.19K |
|
|
TSVT
1556
DELISTED
2seventy bio
TSVT
| $5.24K | ﹤0.01% |
+1,719
| New | +$7.05K |
|
1557
Sutro Biopharma
STRO
$353M
| $5.19K | ﹤0.01% |
+275
| New | +$8.39K |
|
|
SPNS
1558
DELISTED
Sapiens International
SPNS
| $5.03K | ﹤0.01% |
187
-39
| -17% | -$1.25K |
|
1559
Liberty Media Series A
FWONA
$23.7B
| $5.01K | ﹤0.01% |
+59
| New | +$4.59K |
|
1560
TScan Therapeutics
TCRX
$50.5M
| $5.01K | ﹤0.01% |
+1,636
| New | +$7.42K |
|
1561
Biomea Fusion
BMEA
$92.8M
| $4.83K | ﹤0.01% |
1,208
-102
| -8% | -$813 |
|
|
CLYM
1562
Climb Bio
CLYM
$827M
| $4.7K | ﹤0.01% |
+2,240
| New | +$8.11K |
|
1563
PagSeguro Digital
PAGS
$2.44B
| $4.43K | ﹤0.01% |
708
-143
| -17% | -$1.1K |
|
1564
PepGen
PEPG
$201M
| $4.26K | ﹤0.01% |
+1,086
| New | +$6.77K |
|
1565
Liberty Live Group Series A
LLYVA
$9.45B
| $4.25K | ﹤0.01% |
+63
| New | +$3.91K |
|
1566
Enanta Pharmaceuticals
ENTA
$393M
| $4.24K | ﹤0.01% |
+706
| New | +$6.77K |
|
1567
Cipher Digital
CIFR
$7.42B
| $4.11K | ﹤0.01% |
885
-179
| -17% | -$1.02K |
|
1568
Paysafe
PSFE
$352M
| $3.54K | ﹤0.01% |
207
-43
| -17% | -$871 |
|
1569
Blend Labs
BLND
$331M
| $3.49K | ﹤0.01% |
830
-167
| -17% | -$719 |
|
|
OKUR
1570
OnKure Therapeutics
OKUR
$159M
| $3.44K | ﹤0.01% |
422
+301
| +249% | +$4.56K |
|
1571
Liberty Broadband Class A
LBRDA
$5.07B
| $3.4K | ﹤0.01% |
+45
| New | +$3.72K |
|
1572
Editas Medicine
EDIT
$436M
| $3.33K | ﹤0.01% |
2,751
-232
| -8% | -$591 |
|
|
APLT
1573
DELISTED
Applied Therapeutics
APLT
| $3.31K | ﹤0.01% |
+3,877
| New | +$24.3K |
|
1574
Pyxis Oncology
PYXS
$201M
| $3.15K | ﹤0.01% |
+1,982
| New | +$5.72K |
|
|
ML
1575
DELISTED
MoneyLion Inc.
ML
| $3.1K | ﹤0.01% |
36
-7
| -16% | -$472 |
|
Similar funds
Mirae Asset Global Investments's Q4 2024 Portfolio in Review
As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.
- Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
- Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
- Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
- Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
- Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
- Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
- Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.